Literature DB >> 20567803

Tribbles homologue 3 (TRIB3) and the insulin-resistance genes in type 2 diabetes.

F Beguinot1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20567803     DOI： 10.1007/s00125-010-1824-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  23 in total

Review 1.  Tribbles: novel regulators of cell function; evolutionary aspects.

Authors:  Z Hegedus; A Czibula; E Kiss-Toth
Journal:  Cell Mol Life Sci       Date:  2006-07       Impact factor: 9.261

Review 2.  Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?

Authors:  J C Florez
Journal:  Diabetologia       Date:  2008-05-27       Impact factor: 10.122

3.  Evidence for gene-nutrient interaction at the PPARgamma locus.

Authors:  J Luan; P O Browne; A H Harding; D J Halsall; S O'Rahilly; V K Chatterjee; N J Wareham
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

4.  Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans.

Authors:  H Oberkofler; A Pfeifenberger; S Soyal; T Felder; P Hahne; K Miller; F Krempler; W Patsch
Journal:  Diabetologia       Date:  2010-05-13       Impact factor: 10.122

5.  Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?

Authors:  P W Franks; J Luan; P O Browne; A-H Harding; S O'Rahilly; V K K Chatterjee; N J Wareham
Journal:  Metabolism       Date:  2004-01       Impact factor: 8.694

6.  The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes.

Authors:  Sabrina Prudente; Daniela Scarpelli; Manisha Chandalia; Yuan-Yuan Zhang; Eleonora Morini; Silvia Del Guerra; Francesco Perticone; Rong Li; Christine Powers; Francesco Andreozzi; Piero Marchetti; Bruno Dallapiccola; Nicola Abate; Alessandro Doria; Giorgio Sesti; Vincenzo Trischitta
Journal:  J Clin Endocrinol Metab       Date:  2008-11-04       Impact factor: 5.958

7.  Signal transduction mechanism of TRB3 in rats with non-alcoholic fatty liver disease.

Authors:  Yu-Gang Wang; Min Shi; Ting Wang; Ting Shi; Jue Wei; Na Wang; Xi-Mei Chen
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

Review 8.  Complexity of type 2 diabetes mellitus data sets emerging from nutrigenomic research: a case for dimensionality reduction?

Authors:  Jim Kaput; Kevin Dawson
Journal:  Mutat Res       Date:  2007-05-05       Impact factor: 2.433

9.  The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells.

Authors:  O Porzio; M Federici; M L Hribal; D Lauro; D Accili; R Lauro; P Borboni; G Sesti
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

10.  PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus.

Authors:  G Condorelli; G Vigliotta; C Iavarone; M Caruso; C G Tocchetti; F Andreozzi; A Cafieri; M F Tecce; P Formisano; L Beguinot; F Beguinot
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598
View more
  3 in total

1.  Sitagliptin prevents aggravation of endocrine and exocrine pancreatic damage in the Zucker Diabetic Fatty rat - focus on amelioration of metabolic profile and tissue cytoprotective properties.

Authors:  Flávio Reis; Edite Teixeira de Lemos; Cristina Mega; Helena Vala; Paulo Rodrigues-Santos; Jorge Oliveira; Frederico Teixeira; Rosa Fernandes
Journal:  Diabetol Metab Syndr       Date:  2014-03-20       Impact factor: 3.320

Review 2.  Early life factors and type 2 diabetes mellitus.

Authors:  Xinli Jiang; Huijie Ma; Yan Wang; Yan Liu
Journal:  J Diabetes Res       Date:  2013-12-16       Impact factor: 4.011

Review 3.  Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes.

Authors:  Cristina Mega; Edite Teixeira-de-Lemos; Rosa Fernandes; Flávio Reis
Journal:  J Diabetes Res       Date:  2017-08-27       Impact factor: 4.011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.